Surgical revascularization versus best endovascular therapy for chronic limb threatening ischemia with infra-popliteal disease
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference5 articles.
1. Contemporary trends in hospital admissions and outcomes in patients with critical limb ischemia: an analysis from the national inpatient sample database;Anantha-Narayanan;Circ Cardiovasc Qual Outcomes,2021
2. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy;Bradbury;J Vasc Surg,2010
3. Surgery or endovascular therapy for chronic limb-threatening ischemia;Farber;N Engl J Med,2022
4. A comparison of outcomes in patients with Infrapopliteal disease randomised to vein bypass or plain balloon angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL);Popplewell;Trial Eur J Vasc Endovasc Surg,2017
5. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation pr;Bradbury;Lancet,2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3